Navigation Links
Year of Taking Risky Blood Thinners May Be Unnecessary After Stent Surgery
Date:9/20/2012

By Maureen Salamon
HealthDay Reporter

THURSDAY, Sept. 20 (HealthDay News) -- A full year of aggressive anti-clotting therapy -- which can lead to heavy bleeding -- may not be needed after surgery to implant a drug-coated cardiac stent, two new studies suggest.

Standard treatment for patients receiving so-called drug-eluting cardiac stents, which prop open clogged arteries after angioplasty, typically entails 12 months of double anti-platelet therapy consisting of aspirin and prescription blood thinners. Korean and Spanish research indicates, however, that patients who discontinue such risky therapy after several months suffer no more ill effects than those treated for a year.

"The interesting thing is, we went through a period of time so panicked about anti-platelet therapy interruptions and the effect they might have," said Dr. Kirk Garratt, director of clinical research at Lenox Hill Heart and Vascular Institute of New York City, who was not involved in the studies. "But over the last few years, a series of reports and clinical trials say the same thing -- that we probably don't need to be as worked up about it as we used to be."

The studies are scheduled for publication Sept. 21 in the Journal of the American College of Cardiology.

Cardiac stents -- metal mesh tubes that prevent heart arteries from re-closing -- are implanted in more than 500,000 Americans each year, according to the U.S. Centers for Disease Control and Prevention. Some stents are coated with slowly released medication to prevent the growth of scar tissue in the artery lining.

Prescription blood thinners used in double anti-platelet therapy, such as clopidogrel (Plavix) and warfarin (Coumadin), are tricky to dose properly and can lead to life-threatening bleeding complications.

The Korean study split more than 2,100 patients, all of whom underwent stent surgery after angina (chest pain) or a heart attack, into groups treated with either three months of double anti-platelet therapy or the standard 12-month course. After a year, just less than 5 percent of both groups had suffered complications such as death, bleeding, heart attack or clotting near the stent.

The Spanish study addressed interruptions in double anti-platelet therapy due to noncompliance, surgery or other medical decisions in a group of 1,600 patients. Most of the 10.6 percent of patients who discontinued the therapy did so temporarily, but this practice didn't translate into more serious consequences compared to those whose therapy was not interrupted.

"The big takeaway is that neither of these studies fundamentally change the way I think about these therapies for my patients," Garratt said. "But the Spanish study increases my confidence in the way I'm managing these patients."

But Dr. Christopher Cove, associate professor of medicine and assistant director of the cardiac catheterization lab at University of Rochester Medical Center in New York, cautioned it would be a mistake to think it's safe to stop double anti-platelet therapy based on the new research. Larger studies are needed, he added.

"We know that [double anti-platelet therapy] is beneficial as compared to aspirin alone in large groups of patients, and that there's a high risk of bleeding with it," Cove said. "What we really need to know is, if we have to stop double anti-platelet therapy, when is the safe time to do that."

More information

The American Heart Association has more about angioplasty and stents.

SOURCES: Christopher Cove, M.D., associate professor, medicine, and assistant director, cardiac catheterization lab, University of Rochester Medical Center, Rochester, N.Y.; Kirk Garratt, M.D., director, clinical research, Lenox Hill Heart and Vascular Institute of New York, New York City; Sept. 21, 2012, Journal of the American College of Cardiology


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Taking Breaks From Prostate Cancer Hormone Therapy Seems Safe: Study
2. Children taking steroids for asthma are slightly shorter than peers
3. Many Teens Drinking, Taking Drugs During School: Survey
4. More Kids Taking Antipsychotics for ADHD: Study
5. Off-label drug use common, but patients may not know theyre taking them, Mayo finds
6. Taking nothing at face value
7. Taking tissue regeneration beyond the state-of-the-art
8. Taking the fate of stem cells in hand: RUB researchers generate immature nerve cells
9. Young Men Taking HIV Meds May Be at Risk for Bone Loss
10. Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo
11. Taking Anti-HIV Meds Prior to Exposure May Help Prevent Infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Year of Taking Risky Blood Thinners May Be Unnecessary After Stent Surgery
(Date:2/22/2017)... ... February 22, 2017 , ... Doctors on Liens is continuing its ... Dr. Steven H. Rauchman, practicing at North Valley Eye Medical Group in Mission ... premise liability and other personal injury cases. These injuries have a major impact ...
(Date:2/22/2017)... ... February 22, 2017 , ... The first-ever National ... organizations, advocates, and individuals join together to increase recognition about the risks of ... lives. , “Today we mark a nationwide movement to raise awareness about a ...
(Date:2/22/2017)... TX (PRWEB) , ... February 22, 2017 , ... ... the launch of ProGen™ PRP, the latest innovation in the delivery of Platelet ... wound care, aesthetics, cardiovascular and pain management, to accelerate tissue synthesis and provide ...
(Date:2/22/2017)... CT (PRWEB) , ... February 22, 2017 , ... The ... and the 2017 Forecast —on Thursday, February 23, 2017, at 1:00 PM ET. A ... webinar is part of the Interactive Webinar Series. , If you want to find ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... veterans who suffer from combat-related PTSD. , Established in 1977, our organization was ... the challenges of military returning to civilian life were evident and served as ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... , Feb 22, 2017 Research and Markets ... Analysis & Trends - Industry Forecast to 2025" report to their ... The Global Clot ... 5.2% over the next decade to reach approximately $2.1 billion by 2025. ... forecasts for all the given segments on global as well as regional ...
(Date:2/22/2017)... Research and Markets has announced the addition of the ... Trend Indicator):Analysis By Region, By Country (2016-21)" report to their ... Global ... CAGR of 5.33% during 2016-2021 The strong growth is ... demand of digital thermometer. Apart from that, the downfall in the ...
(Date:2/22/2017)... DUBLIN , Feb. 22, 2017  Allergan ... is proud to be a Gold sponsor of ... National Educating America Tour." This tour commemorates AFA,s15 ... availability of services and programs. The tour will ... free memory screenings and displays of the AFA ...
Breaking Medicine Technology: